Original Research
Jun 10
Antonin Trimaille, Josep Rodés-Cabau, et al.
This large-scale, international study found that early haemodynamic valve deterioration occurred in 3.1% of TAVI patients and was independently associated with adverse clinical and haemodynamic outcomes during long-term follow-up.
Editorial
Jun 11
Ron Waksman, Asa Phichaphop
The article explores the factors that influence long-term outcomes after TAVI, emphasizing the need for more research to optimize valve performance and understand the clinical significance of early post-procedure valve changes.
free
Research Correspondence
Jun 9
Rodrigo Estévez-Loureiro, Neil Fam, et al.
This study reports on the compassionate use of the Unica cross-caval valve implantation device, which achieved high procedural success and significant hemodynamic improvement in patients with severe tricuspid regurgitation.
Original Research
Jun 8
Giuseppe Tarantini, Radoslaw Parma, et al.
This article provides an overview of the various interventional procedures available in cardiology, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.
State-of-the-Art
Jun 4
Heberto Aquino Bruno, Giuseppe Tarantini, et al.
This review provides a comprehensive overview of coronary interventions related to transcatheter aortic valve implantation (TAVI), covering coronary evaluation, indications and timing of percutaneous coronary intervention, and strategies for managing coronary obstruction.
free
new issue
Jun 1
A State-of-the-Art on TAVI and coronary interventions; early haemodynamic valve deterioration after TAVI; 30-day outcomes of redo-TAVI with SAPIEN 3; Unica device for tricuspid regurgitation; the UNICORN technique in native valves; and more
Debate
Jun 1
Dominick J. Angiolillo, Marco Valgimigli, et al.
There is an ongoing debate over whether prasugrel or ticagrelor should be the preferred P2Y12 inhibitor for patients with acute coronary syndromes, as the available evidence comparing the two remains inconclusive.
free
Flashlight
Jun 3
Jean-Benoît Veillette, Jean-Michel Paradis, et al.
This case report describes the use of the UNICORN technique to prevent left coronary obstruction during TAVI in an 84-year-old female with severe native aortic stenosis.
Original Research
May 29
David E. Kandzari, Felix Mahfoud, et al.
This study found significant blood pressure reductions through 36 months and that nearly 9 out of 10 patients experienced a clinical benefit after radiofrequency renal denervation using the Symplicity Spyral device.
open access
Original Research
May 29
Oskar Love Emilsson, Sasha Koul et al.
In ACS patients on DOACs undergoing PCI, ticagrelor was associated with a higher bleeding risk compared to clopidogrel, with no differences in ischemic outcomes.
open access
Editorial
May 29
Diana A. Gorog, Konstantinos Toutouzas
The SWEDEHEART registry suggests that adding ticagrelor to a direct oral anticoagulant (DOAC) in patients with non-valvular atrial fibrillation and acute coronary syndrome may be akin to using a sledgehammer where a scalpel is required.
free
Original Research
May 28
Emil N. Holck, Evald H. Christiansen, et al.
This study assessed the feasibility and clinical outcomes of optical coherence tomography (OCT) guidance versus angiographic guidance in percutaneous coronary intervention (PCI) for true left main coronary artery (LMCA) bifurcation lesions. OCT guidance was feasible but with limited visibility of the LMCA ostium, and did not significantly improve clinical outcomes.
Original Research
May 28
Hans-Josef Feistritzer, Mohamed Abdel-Wahab, et al.
In this randomized trial, TAVI with the ACURATE neo2 valve was non-inferior to the Evolut platform, with significantly lower rates of the primary composite endpoint at 30 days, driven by lower permanent pacemaker implantation.
Editorial
May 28
Stefan Blankenberg and Sebastian Ludwig
The DOUBLE-CHOICE trial demonstrated the non-inferiority of the ACURATE neo2 transcatheter heart valve compared to other contemporary valves in the treatment of severe aortic stenosis, with lower rates of the primary endpoint and paravalvular leak.
free
